glp-1 and ibd Pharmacological interventions for obesity in patients with inflammatory bowel disease: A systematic review of receptor agonist efficacy safety Role of glucagon-like peptides in
Description
These products differ fundamentally from prescription GLP-1 receptor agonist medications, which have robust clinical evidence and MHRA approval
,
[DOI] [PMC free article] [PubMed] [Google Scholar] 27.Dhillon S
& Grigson, P
Cons: Makes claims that the supplement is made in a FDA-approved facility, however, lacks transparency with third-party testing information
[Google Scholar] 33
